Article may be outdated

This article is 72 days old. Some details may have changed since publication.

Medical Xpress·3 min read·hard

Biological pacemaker dogma challenged as TBX18 fails and Hcn2 delivers

Biological pacemaker dogma challenged as TBX18 fails and Hcn2 delivers
AI Summary

Researchers at Amsterdam UMC have discovered that the transcription factor TBX18 is toxic and ineffective as a biological pacemaker, while the ion channel Hcn2 shows promise. This finding challenges long-standing assumptions in cardiac research.

Why it matters

This study corrects a decade-old scientific misconception, potentially redirecting future research toward safer and more effective biological heart therapies.

Dive DeeperCreate a free account to unlock

edited by Sadie Harley , reviewed by Robert Egan

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%

The report is a straightforward summary of a peer-reviewed scientific study without subjective framing.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in